# Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells

> **NCT04484402** · PHASE1,PHASE2 · COMPLETED · sponsor: **Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus** · enrollment: 25 (actual)

## Conditions studied

- Corneal Ulcer
- Corneal Disease
- Corneal Dystrophy

## Interventions

- **BIOLOGICAL:** mesenchymal stem cells
- **BIOLOGICAL:** limbal stem cells
- **OTHER:** standard treatment

## Key facts

- **NCT ID:** NCT04484402
- **Lead sponsor:** Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-03
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484402, "Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04484402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*